ARTICLE | Company News
Quest Diagnostics sales and marketing update
October 21, 2013 7:00 AM UTC
Quest launched BRCAvantage, a suite of four laboratory-developed genetic tests that identify breast cancer 1 early onset (BRCA1) and BRCA2 mutations, which are associated with increased risk of inhe...